0001493152-23-002085.txt : 20230120 0001493152-23-002085.hdr.sgml : 20230120 20230120200013 ACCESSION NUMBER: 0001493152-23-002085 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230118 FILED AS OF DATE: 20230120 DATE AS OF CHANGE: 20230120 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Leon Francisco CENTRAL INDEX KEY: 0001728920 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38552 FILM NUMBER: 23542304 MAIL ADDRESS: STREET 1: C/O PROVENTION BIO, INC. STREET 2: 110 OLD DRIFTWAY LANE CITY: LEBANON STATE: NJ ZIP: 08833 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Provention Bio, Inc. CENTRAL INDEX KEY: 0001695357 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 55 BROAD STREET, 2ND FLOOR CITY: RED BANK STATE: NJ ZIP: 07701 BUSINESS PHONE: 908-428-9136 MAIL ADDRESS: STREET 1: 55 BROAD STREET, 2ND FLOOR CITY: RED BANK STATE: NJ ZIP: 07701 FORMER COMPANY: FORMER CONFORMED NAME: Provention Inc. DATE OF NAME CHANGE: 20170120 4 1 ownership.xml X0306 4 2023-01-18 0 0001695357 Provention Bio, Inc. PRVB 0001728920 Leon Francisco C/O PROVENTION BIO, INC. 55 BROAD STREET, 2ND FLOOR RED BANK NJ 07701 0 1 0 0 Chief Scientific Officer Common Stock 2023-01-18 4 M 0 24015 2.5 A 1597015 D Common Stock 2023-01-18 4 S 0 24015 10.2679 D 1573000 D Common Stock 1000000 I By Trust Stock Option (right to buy) 2.5 2023-01-18 4 M 0 24015 0 D 2027-04-25 Common Stock 24015 318088 D The sales reported on this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 19, 2022. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.13 to $10.41 per share, inclusive. The reporting person undertakes to provide to Provention Bio, Inc., any security holder of Provention Bio, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. The option is fully vested. /s/ Thierry Chauche, as attorney-in-fact 2023-01-20